| Financial Year |
March 31 2023 |
| Monetary Funds |
265,661,514.60 |
| Held-for-trading Financial Assets |
1,000,000.00 |
| Notes Receivable |
2,171,586.24 |
| Accounts Receivable |
143,554,121.97 |
| Advances to Suppliers |
2,898,543.85 |
| Other Receivables |
14,313,566.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
69,854,891.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,854,764.89 |
| Total Current Assets |
508,480,372.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,973,289.04 |
| Investment Properties |
136,538,058.77 |
| Fixed Assetes |
49,096,117.50 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,254,137.94 |
| R&D expenses |
-- |
| Goodwill |
9,091,564.21 |
| Long-Term Deferred and Prepaid Expenses |
3,349,277.78 |
| Deferred Income Tax Assets |
1,868,731.95 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
290,491,170.08 |
| Total Assets |
798,971,542.24 |
| Short-Term Loans |
23,026,011.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,507,149.75 |
| Accounts Payable |
49,621,131.94 |
| Accounts Received In Advance |
8,375,366.78 |
| Employee Compensation Payable |
13,709,245.58 |
| Taxes Payable |
41,202,473.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,466,348.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,889,503.34 |
| Other Current Liabilities |
211,075.00 |
| Sub-Total of Current Liabilities |
192,076,627.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,730.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,332,578.81 |
| Total Liabilities |
203,409,206.22 |
| Paid-In Capital(Or Share Stock) |
219,989,902.00 |
| Capital Surplus |
826,168,328.31 |
| Surplus Reserve |
37,300,095.44 |
| LESS:Treasury Stock |
60,432,485.96 |
| Undistributed Profits |
-414,207,981.47 |
| Minority Stockholder's Interest |
-1,868,985.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
597,431,321.99 |
| Owner's Equity（Stockholder's Equity） |
595,562,336.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
798,971,542.24 |
